cgp 39551 has been researched along with phenobarbital in 1 studies
Studies (cgp 39551) | Trials (cgp 39551) | Recent Studies (post-2010) (cgp 39551) | Studies (phenobarbital) | Trials (phenobarbital) | Recent Studies (post-2010) (phenobarbital) |
---|---|---|---|---|---|
75 | 0 | 4 | 18,336 | 619 | 1,117 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Czechowska, G; Czuczwar, SJ; Dziki, M; Kleinrok, Z; Pietrasiewicz, T; Turski, WA | 1 |
1 other study(ies) available for cgp 39551 and phenobarbital
Article | Year |
---|---|
Competitive NMDA receptor antagonists enhance the antielectroshock activity of various antiepileptics.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Avoidance Learning; Behavior, Animal; Carbamazepine; Drug Synergism; Electroshock; Male; Memory; Mice; Motor Activity; Phenobarbital; Phenytoin; Receptors, N-Methyl-D-Aspartate; Seizures | 1993 |